Ironwood Pharmaceuticals IRWD Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's total costs & expenses?
- Ironwood Pharmaceuticals (IRWD) reported total costs & expenses of $33.93M in Q1 2026.
- How has Ironwood Pharmaceuticals's total costs & expenses changed year-over-year?
- Ironwood Pharmaceuticals's total costs & expenses decreased by 51.7% year-over-year, from $70.25M to $33.93M.
- What is the long-term trend for Ironwood Pharmaceuticals's total costs & expenses?
- Over 4 years (2021 to 2025), Ironwood Pharmaceuticals's total costs & expenses has grown at a 2.2% compound annual growth rate (CAGR), from $181.49M to $197.65M.
- What does total costs & expenses mean?
- This metric aggregates all operating and non-operating costs incurred by the company to generate revenue during a specific period. It includes the sum of cost of goods sold, research and development, and selling, general, and administrative expenses. Analyzing this figure helps investors evaluate the company's overall cost structure and operational discipline in relation to its top-line performance.